F. J. Dein
M. Fuchsberger
B.C. Fox
D.T. Stinchcomb
J.G. Osorio
Tonie E. Rocke
2004
<p><span>A laboratory accident resulted in human exposure to a recombinant raccoon poxvirus (RCN) developed as a vaccine vector for antigens of </span><i>Yersinia pestis</i><span><span> </span>for protection of wild rodents (and other animals) against plague. Within 9 days, the patient developed a small blister that healed within 4 weeks. Raccoon poxvirus was cultured from the lesion, and the patient developed antibody to plague antigen (F1) and RCN. This is the first documented case of human exposure to RCN.</span></p>
application/pdf
10.1016/j.vaccine.2004.01.030
en
Elsevier
Limited infection upon human exposure to a recombinant raccoon pox vaccine vector
article